Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Breast Neoplasms, Male × Cyclophosphamide × 90 days × Clear all

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 38 Lymphoma, Large B-Cell, Diffuse 38 Multiple Myeloma 27 Lymphoma 25 Leukemia, Myeloid, Acute 25 Burkitt Lymphoma 25 Breast Neoplasms 24 Lymphoma, Follicular 23 Leukemia, Lymphocytic, Chronic, B-Cell 22 Neoplasms 21 Lymphoma, Non-Hodgkin 21 Lymphoma, B-Cell 16 Myelodysplastic Syndromes 15 Lymphoma, Mantle-Cell 15 Hematologic Neoplasms 15 Leukemia 14 Melanoma 13 Lymphoma, B-Cell, Marginal Zone 13 Triple Negative Breast Neoplasms 12 Recurrence 12 Ovarian Neoplasms 11 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 11 Hodgkin Disease 11 Pancreatic Neoplasms 10 Neuroblastoma 10 Medulloblastoma 10 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 9 Leukemia, Biphenotypic, Acute 9 Brain Neoplasms 9 Neoplasm Metastasis 8

Interventions

exemestane 2 Tamoxifen 2 Leuprolide 2 Letrozole 2 Immunotherapy 2 Goserelin 2 Anastrozole 2 ribociclib 1 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1 abemaciclib 1 Neoadjuvant Therapy 1 Immunoenzyme Techniques 1 Everolimus 1 Blood Specimen Collection 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡